Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · April 28, 2023

Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults With Type 1 Diabetes

Diabetes Technology & Therapeutics

 

Additional Info

Diabetes Technology & Therapeutics
Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial
Diabetes Technol. Ther. 2023 Apr 01;25(4)250-259, MJ Burnside, DM Lewis, HR Crocket, RA Meier, JA Williman, OJ Sanders, CA Jefferies, AM Faherty, RG Paul, CS Lever, SKJ Price, CM Frewen, SD Jones, TC Gunn, C Lampey, BJ Wheeler, MI de Bock

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading